Skip to main content
AHGAkso Health GroupSell3.5·$1.41+6.02%
Open full analysis

Akso Health Group (AHG) Stock Analysis

SellModerate Confidence

Healthcare · Medical Distribution

Sell if holding. Engine safety override at $1.41: Quality below floor (1.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.5/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend.

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and... Read more

$1.41+51.1% A.UpsideScore 3.5/10#5 of 5 Medical Distribution
QualityF-score4 / 9FCF yield-14.86%
Stop $1.29Target $2.10(resistance)A.R:R 0.0:1

Sell if holding. Engine safety override at $1.41: Quality below floor (1.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.5/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. Chart setup: No clear chart pattern; technical signals are mixed. Score 3.5/10, moderate confidence.

Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-09

Recent Developments — Akso Health Group

Generated 2026-06-15T18:11:46Z.

Thesis

Rewards
No bull case signals
Risks
Quality below floor (1.5 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)
Mkt Cap$1.1B
EV/EBITDA-2331.3
Profit Mgn0.0%
ROE-68.3%
Rev Growth0.9%
Beta-1.02
DividendNone
Rating analysts

Quality Signals

Piotroski F4/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
0.0
Quality Rank
0.0
Growth Rank
0.0

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Roe
0.0
Roa
0.0
Gross Margin
0.0
Operating Margin
0.0
Net Margin
0.0
Fcf Quality
0.0
Moat
3.1
Piotroski F
4.4
Current Ratio
5.6
Cash-burning: FCF -1141% of revenueNo competitive moatQuality concerns

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume
0.0
Obv
1.0
Ma Position
2.2
Rsi
3.0
Macd
3.8
Capitulation risk (RSI 29, below 200MA)Volume distribution (falling OBV)Below 200-MA but MA still rising (+0.0%/30d) — pullback in uptrend, not confirmed weakness

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
2.7
Low model confidence on this dimension (33%).
GatesMomentum 2.0<4.5A.R:R UPSIDE_EXHAUSTED (upside=0.0%)Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
29 · Oversold
20D MA 50D MA 200D MAGOLDEN CROSSSupport $1.24Resistance $2.14

Price Targets

$1
$2
A.Upside+48.9%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (1.5 < 4.0)
! momentum at 2.0 (below the engine's 4.5 threshold)

Earnings

B
B
M
M
2/4 beats

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AHG stock a buy right now?

Sell if holding. Engine safety override at $1.41: Quality below floor (1.5 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.5/10. Specifically: Below-average business quality; Negative price momentum; Below long-term trend. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $1.29. Score 3.5/10, moderate confidence.

What is the AHG stock price target?

Take-profit target: $2.10 (+51.1% upside). Prior stop was $1.29. Stop-loss: $1.29.

What are the risks of investing in AHG?

Quality below floor (1.5 < 4.0).

Is AHG overvalued or undervalued?

Akso Health Group trades at a P/E of N/A (forward N/A). TrendMatrix value score: 5.0/10. Verdict: Sell.

0
What does Akso Health Group do?Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's...

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Related stocks: HSIC (Henry Schein, Inc.) · AUPH (Aurinia Pharmaceuticals Inc) · GMED (Globus Medical, Inc.) · PODD (Insulet Corporation) · INDV (Indivior Pharmaceuticals, Inc.)
Home Stocks AHG

Latest news

Latest News

Benzinga40d ago
Benzinga49d agoProduct
Benzinga70d ago